Galliprant 20 Mg 30s
Elanco Animal Health |
CA5810030AL

Galliprant 20 Mg 30s

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description
Galliprant (grapiprant tablets) is the newest active ingredient approved to control the pain and inflammation associated with OA in dogs. Galliprant is part of a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs).

Active Ingredient
Grapiprant – 20mg

Galliprant 20mg is a next-generation non-steroidal anti-inflammatory drug (NSAID) specifically developed to manage pain and inflammation caused by osteoarthritis in dogs. It contains the active ingredient grapiprant, a selective EP4 receptor antagonist, which provides targeted relief while minimising the risk of gastrointestinal, kidney, and liver side effects commonly associated with traditional NSAIDs.
This strength is suitable for small to medium-sized dogs as determined by a veterinarian.

Key Features
  • Effective daily pain relief for canine osteoarthritis
  • Non-COX inhibiting action – safer for long-term use
  • Targets the EP4 receptor, a key mediator of canine arthritis pain
  • Once-daily dosing with or without food
  • Flavoured chewable tablets for easy administration


Pack Size
30 flavoured tablets (20mg each)

Precautions
Not for use in dogs under 9 months of age or under 3.6kg
Do not use in dogs with known hypersensitivity to grapiprant
Should not be used with other NSAIDs or corticosteroids
Regular veterinary monitoring is advised during prolonged treatment
Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Categorisation:
Prescription